The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the
resistance of HCC cells to traditional treatments and tumor recurrence after curative …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The
cancer stem cells (CSCs) of HCC are responsible for tumor growth, invasion, metastasis …

Hepatocellular carcinoma (HCC), one of the most common and lethal tumors worldwide, is
usually not diagnosed until the disease is advanced, which results in ineffective intervention …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death
worldwide. Chronic infection of hepatitis B virus (HBV) and/or hepatitis C virus (HCV) is a …

Cell differentiation within stem cell lineages can check proliferative potential, but nodal
pathways that can limit tumor growth are obscure. Here, we report that lung cancer cell …

Various stem cell markers (eg, epithelial cell adhesion molecule [EpCAM], cytokeratin 19
[K19]) have been reported as predictors of poor prognosis in hepatocellular carcinoma …

Protein-based cancer therapies are considered an alternative to conventional anticancer
regimens, providing multifunctional properties while showing low toxicity. However, its …

Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality rate.
It is a heterogeneous cancer with diverse inter-and intra-heterogeneity, also in terms of …

Hepatocellular carcinoma (HCC) is the fourth most common cause of death among cancers.
The poor prognosis of HCC might be caused by a population of cancer stem cells (CSC) …

Hepatocellular carcinoma (HCC) is one of the global health concerns. Hepatitis B virus
(HBV) is one of the major causes of HCC. Poor clinical outcome of HCC patients is attributed …